SHANGHAI, Oct. 11 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics," the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced that its management will attend the BNP Paribas 17th Annual China Conference on October 13-15 in Guilin, China.
China-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC mainly through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The Company also sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .
For more information, please contact: Travis Cai Chief Financial Officer China-Biotics, Inc. Email: firstname.lastname@example.org Shiwei Yin/Kevin Theiss Grayling Tel: +1-646-284-9474 Email: email@example.com firstname.lastname@example.org
SOURCE China-Biotics, Inc.